Latest news
AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile - MorningstarMorningstar · Mon, 10 Aug 2026 11:00:00 GMTMannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTLungpacer Announces Health Economic Analysis Demonstrating Clinical and Cost Benefits of AeroPace in Mechanically Ventilated Patients - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 11:15:39 GMTOrganogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 07:00:00 GMT